← boothcheck

Is DOC overvalued?

boothcheck doesn't label DOC overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, DOC is priced for growth of -3.0%. The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price. The more the price assumes beyond what Healthpeak Properties, Inc. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from Healthpeak Properties, Inc.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 28, 2026.

Implied growth-3.0%
For about
Margin needed
Margin today
Price vs asset value8.47x
Price vs earnings power3.70x
Price vs peer multiples0.91x
Price vs forward growth1.11x
Read the full DOC report →
Get boothcheck's read on what DOC's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.